Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHA:600671)
China flag China · Delayed Price · Currency is CNY
14.75
-0.30 (-1.99%)
Nov 18, 2026, 3:00 PM CST

SHA:600671 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
202.54211.7216.91121.52107.97146.55
Other Revenue
0.060.060.390.260.940.52
202.59211.75217.3121.78108.91147.07
Revenue Growth
-19.46%-2.55%78.44%11.82%-25.95%-28.82%
Cost of Revenue
102.72111.59116.6298.3793.74106.45
Gross Profit
99.87100.16100.6823.4115.1640.62
Selling, General & Admin
79.581.5965.8447.3751.5263.18
Research & Development
--1.210.481.581.33
Other Operating Expenses
2.332.561.91.050.951.25
Operating Expenses
81.0786.1271.2445.9159.0569.81
Operating Income
18.814.0429.44-22.5-43.89-29.19
Interest Expense
-2.15-7.2-5.56-7.19-7.4-7.35
Interest & Investment Income
2.641.850.480.111.020.1
Other Non Operating Income (Expenses)
-11.57-0.174.87-2.53-2.74-0.33
EBT Excluding Unusual Items
7.738.5229.23-32.1-53.01-36.78
Impairment of Goodwill
---0.58--0.53-2.92
Gain (Loss) on Sale of Investments
----0.53--
Gain (Loss) on Sale of Assets
-0.010.17-0.210.15-0.090.04
Asset Writedown
-0.39-0.93--6.01-17.24-
Other Unusual Items
3.92.470.642.18-1.55.92
Pretax Income
11.2410.2229.07-36.31-72.37-33.73
Income Tax Expense
4.953.027.212.990.76-0.95
Earnings From Continuing Operations
6.297.221.87-39.3-73.12-32.78
Minority Interest in Earnings
5.2310.42-6.621.025.612.98
Net Income
11.5217.6215.25-38.28-67.52-29.8
Net Income to Common
11.5217.6215.25-38.28-67.52-29.8
Net Income Growth
-65.25%15.59%----
Shares Outstanding (Basic)
122122122122122124
Shares Outstanding (Diluted)
122122122122122124
Shares Change
0.12%0.01%-0.01%-0.00%-1.92%1.13%
EPS (Basic)
0.090.140.13-0.31-0.55-0.24
EPS (Diluted)
0.090.140.13-0.31-0.55-0.24
EPS Growth
-65.29%15.57%----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
49.76-19.39-57.23-29.38-22.89-31.13
Free Cash Flow Per Share
0.41-0.16-0.47-0.24-0.19-0.25
Gross Margin
49.30%47.30%46.33%19.23%13.92%27.62%
Operating Margin
9.28%6.63%13.55%-18.48%-40.30%-19.85%
Profit Margin
5.69%8.32%7.02%-31.43%-62.00%-20.26%
Free Cash Flow Margin
24.56%-9.16%-26.34%-24.13%-21.02%-21.17%
EBITDA
35.2328.541.29-11.34-29.02-19.56
EBITDA Margin
17.39%13.46%19.00%-9.31%-26.65%-13.30%
D&A For EBITDA
16.4214.4611.8511.1614.869.64
EBIT
18.814.0429.44-22.5-43.89-29.19
EBIT Margin
9.28%6.63%13.55%-18.48%-40.30%-19.85%
Effective Tax Rate
44.03%29.55%24.79%---
Revenue as Reported
52.81211.75217.3121.78108.91147.07
Advertising Expenses
-2.651.190.90.770.46